The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Guillermo Torre-Amione

Methodist DeBakey Heart Center

Baylor College of Medicine

Houston

Texas 77030

USA

[email]@bcm.tmc.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Methodist DeBakey Heart Center, Baylor College of Medicine, Houston, Texas 77030, USA. 2004 - 2005
  • Section of Cardiology, Methodist DeBakey Heart Center and Baylor College of Medicine, Texas Medical Center, One Baylor Plaza, USA. 2003
  • Winters Center for Heart Failure Research, the Eugene and Judith Campbell Laboratories for Cardiac Transplantation Research, Houston, Texas, USA. 2001

References

  1. Immune activation in chronic heart failure. Torre-Amione, G. Am. J. Cardiol. (2005) [Pubmed]
  2. Broad modulation of tissue responses (immune activation) by celacade may favorably influence pathologic processes associated with heart failure progression. Torre-Amione, G., Sestier, F., Radovancevic, B., Young, J. Am. J. Cardiol. (2005) [Pubmed]
  3. Effects of a novel immune modulation therapy in patients with advanced chronic heart failure: results of a randomized, controlled, phase II trial. Torre-Amione, G., Sestier, F., Radovancevic, B., Young, J. J. Am. Coll. Cardiol. (2004) [Pubmed]
  4. Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure. Torre-Amione, G., Young, J.B., Colucci, W.S., Lewis, B.S., Pratt, C., Cotter, G., Stangl, K., Elkayam, U., Teerlink, J.R., Frey, A., Rainisio, M., Kobrin, I. J. Am. Coll. Cardiol. (2003) [Pubmed]
  5. Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure. Torre-Amione, G., Young, J.B., Durand, J., Bozkurt, B., Mann, D.L., Kobrin, I., Pratt, C.M. Circulation (2001) [Pubmed]
  6. A pilot safety trial of prolonged (48 h) infusion of the dual endothelin-receptor antagonist tezosentan in patients with advanced heart failure. Torre-Amione, G., Durand, J.B., Nagueh, S., Vooletich, M.T., Kobrin, I., Pratt, C. Chest (2001) [Pubmed]
 
WikiGenes - Universities